SLC5A12

Chr 11

solute carrier family 5 member 12

Also known as: SMCT2

The SLC5A12 protein functions as a low-affinity sodium-coupled transporter that mediates reabsorption of monocarboxylates including lactate, pyruvate, and other organic acids in the proximal tubule of the kidney and small intestine. Mutations in SLC5A12 cause autosomal recessive renal lactate wasting, which can lead to metabolic complications due to impaired lactate reabsorption. This gene is not highly constrained against loss-of-function variants, consistent with its recessive inheritance pattern.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
7
Pubs (1 yr)
21
P/LP submissions
0%
P/LP missense
0.70
LOEUF
Multiple*
Mechanism· predicted
Clinical SummarySLC5A12
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
21 unique Pathogenic / Likely Pathogenic· 83 VUS of 118 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.70LOEUF
pLI 0.000
Z-score 2.95
OE 0.46 (0.310.70)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
1.15Z-score
OE missense 0.82 (0.740.91)
267 obs / 325.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.46 (0.310.70)
00.351.4
Missense OE0.82 (0.740.91)
00.61.4
Synonymous OE1.01
01.21.6
LoF obs/exp: 16 / 34.7Missense obs/exp: 267 / 325.5Syn Z: -0.09
DN
0.82top 10%
GOF
0.78top 25%
LOF
0.1993th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

118 submitted variants in ClinVar

Classification Summary

Pathogenic20
Likely Pathogenic1
VUS83
Likely Benign4
20
Pathogenic
1
Likely Pathogenic
83
VUS
4
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
20
0
20
Likely Pathogenic
0
0
1
0
1
VUS
0
75
8
0
83
Likely Benign
0
2
0
2
4
Benign
0
0
0
0
0
Total077292108

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

SLC5A12 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →